연구성과로 돌아가기

2024 연구성과별 연구자 정보 (647 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Kim, Tae Hoon Kim, TH 17 Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Chang Won, South Korea D-7205-2016 Kim, Chang-Hoon fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Ahn, June Hong Ahn, JH 18 교신저자 Yeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea AAB-3093-2019 Ahn, June fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Ahn, June Hong Ahn, JH 18 교신저자 Yeungnam Univ, Coll Med, Dept Internal Med, Div Pulmonol & Allergy, 170 Hyeonchung Ro, Daegu 42415, South Korea AAB-3093-2019 Ahn, June fireajh@gmail.com;
Durvalumab Consolidation After Chemoradiotherapy in Elderly Patients With Unresectable Stage III NSCLC: A Real-World Multicenter Study Ahn, June Hong Ahn, JH 18 교신저자 Yeungnam Univ, Resp Ctr, Med Ctr, 170 Hyeonchung Ro, Daegu 42415, South Korea AAB-3093-2019 Ahn, June fireajh@gmail.com;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Cho, Hee Jin Cho, HJ 1 Kyungpook Natl Univ, Dept Biomed Convergence Sci & Technol, CMRI, Daegu, South Korea hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Yun, Kum-Hee Yun, KH 2 Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea 0009-0006-5268-3191 Yun, Kum-Hee hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Shin, Su-Jin Shin, SJ 3 Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Pathol, Seoul, South Korea I-6927-2019 KIM, JIN hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Lee, Young Han Lee, YH 4 Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea AAF-2400-2020 Lee, Jeong Hoon 0000-0002-5602-391X Lee, Young Han hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Kim, Seung Hyun Kim, SH 5 Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea D-5568-2011 Kim, Hyun 0000-0002-3878-1944 Kim, Seung Hyun hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Baek, Wooyeol Baek, W 6 Yonsei Univ, Coll Med, Dept Plast Surg, Seoul, South Korea hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Han, Yoon Dae Han, YD 7 Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea W-1325-2019 Han, Yoondae 0000-0002-2136-3578 Han, Yoondae hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Kim, Sang Kyum Kim, SK 8 Yonsei Univ, Severance Hosp, Coll Med, Dept Pathol, Seoul, South Korea 0000-0003-0768-9923 Kim, Sang Kyum hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Ryu, Hyang Joo Ryu, HJ 9 Yonsei Univ, Severance Hosp, Coll Med, Dept Pathol, Seoul, South Korea hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Lee, Joohee Lee, JH 10 Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea 0000-0002-7721-8935 Lee, Joohee hyosong77@yuhs.ac;
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial Cho, Iksung Cho, IK 11 Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea hyosong77@yuhs.ac;
페이지 이동: